Mount Sinai
Linus Biotechnology Raises $16M in Series A Funding
The Mount Sinai spinout will use the funds to advance its StrandDx platform, correlating environmental exposures to biological responses.
Gene Signature Reflects Host Response to COVID-19 Infections With Low Cross-Reactivity
The researchers established a framework to generate robust host infection response signatures with the aim of improving diagnostic sensitivity.
Researchers have used qPCR to measure the transcripts from monocytes that are activated by T cells to help understand a patient's immune status.
Blood-Based PD-L1 Tracking Could Offer Improved Response Prediction for Lung Cancer Immunotherapy
Premium
While the results are from a small study, investigators are working to validate them in larger groups, hoping their method can prove itself for clinical use.
BioMark Diagnostics, Icahn Mount Sinai to Develop Multiomic Lung Cancer Tests
The partners also aim to develop a test for determining lung cancer subtype and stage using circulating tumor cells and metabolomics.